CRISPR Therapeutics files initial beneficial ownership statement for CFO Andrew Jacob Silver
CRSP•CFO Andrew Jacob Silver filed an initial statement of beneficial ownership dated October 21, 2026.
1. Ownership filing
CRISPR Therapeutics Chief Financial Officer Andrew Jacob Silver filed an initial statement of beneficial ownership dated October 21, 2026.
